This is exemplified in the enrichment of cancer-associated metabolic and proliferative events, such as integrin signaling, IF1/2-mediated events, Syndecan-2-mediated signaling and uPA/uPAR-mediated signaling, and MYC and associated transcription factors. This evidence concerns the gene PLAUR and cancer.